For the Inventor, By the Inventor

Enter assignee name

Chicago, IL, United States of America

Usher III Initiative, Inc.

USPTO Granted Patents = 9

CIPO Patents = 1

EPO Patents = 5

Forward Citations = 28

Loading Chart...

Loading Chart...

7 inventors (with patents filed for the assignee):

Karine Fabienne Malagu (9 out of 25 patents)

Roland Werner Bürli (9 out of 9 patents)

Christopher James Lock (9 out of 10 patents)

4. Andrew Pate Owens (9 out of 33 patents)

5. William E Harte (9 out of 9 patents)

6. William Rameshchandra Krishna Esmieu (8 out of 8 patents)

7. William Rameschandra Krishna Esmieu (1 out of 1 patent)

8. Roland Werner Burli (2 patents)

9. David A Saperstein (7 patents)

10. James M Hamby (2 patents)

11. Tracey L Fletcher (0 patent)

12. Mahdi Farhan (0 patent)

13. William Rameshchandra Esmieu (0 patent)

14. William Edward Harte (0 patent)

15. William Edward Harte (0 patent)

9 patents: Sort by Forward Citations

1. 10307422 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome (2019-06-04),

2. 9925187 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome (2018-03-27),

3. 9783545 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome (2017-10-10),

4. 9549910 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome (2017-01-24),

5. 9371332 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher syndrome (2016-06-21),

6. 9260381 - Pyrazolopyridazines and methods for treating retinal degenerative diseases and hearing loss associated with usher syndrome (2016-02-16),

7. 9227976 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome (2016-01-05),

8. 9079909 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with Usher Syndrome (2015-07-14),

9. 8765762 - Pyrazolopyridazines and methods for treating retinal-degerative diseases and hearing loss associated with usher syndrome (2014-07-01),

Usher III Initiative, Inc. is a non-profit organization dedicated to empowering individuals affected by Usher syndrome type III. We provide support, resources, and education to improve the quality of life for those living with this rare genetic disorder. Through advocacy and community outreach, we strive to raise awareness and fund research towards finding a cure. Join us in our mission to make a difference in the lives of those impacted by Usher syndrome type III.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

9 Patents

#361 in Chicago, IL

#1,502 in Illinois

#31,684 in US

Chicago, IL, United States of America

Usher III Initiative, Inc.

Forward Citations = 28

7 inventors:

Karine Fabienne Malagu (9 out of 25 patents)

Roland Werner Bürli (9 out of 9 patents)

Christopher James Lock (9 out of 10 patents)

4. Andrew Pate Owens (9 out of 33 patents)

5. William E Harte (9 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…